ECSP056039A - Formulacion farmaceutica peroral para agentes antagonistas de bombas de protones - Google Patents

Formulacion farmaceutica peroral para agentes antagonistas de bombas de protones

Info

Publication number
ECSP056039A
ECSP056039A EC2005006039A ECSP056039A ECSP056039A EC SP056039 A ECSP056039 A EC SP056039A EC 2005006039 A EC2005006039 A EC 2005006039A EC SP056039 A ECSP056039 A EC SP056039A EC SP056039 A ECSP056039 A EC SP056039A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical formulation
antagonist agents
pump antagonist
protection pump
peroral pharmaceutical
Prior art date
Application number
EC2005006039A
Other languages
English (en)
Inventor
Rango Dietrich
Hartmut Ney
Simone Hiltl
Bernd-Michael Haas
Original Assignee
Altana Pharma A G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma A G filed Critical Altana Pharma A G
Publication of ECSP056039A publication Critical patent/ECSP056039A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

El invento se refiere a nuevas formas de dosificación para agentes antagonistas de bombas de protones.
EC2005006039A 2003-04-11 2005-09-26 Formulacion farmaceutica peroral para agentes antagonistas de bombas de protones ECSP056039A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10317023A DE10317023A1 (de) 2003-04-11 2003-04-11 Perorale Arzneimittelzubereitung für Protonenpumpenantagonisten

Publications (1)

Publication Number Publication Date
ECSP056039A true ECSP056039A (es) 2006-01-27

Family

ID=33154195

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005006039A ECSP056039A (es) 2003-04-11 2005-09-26 Formulacion farmaceutica peroral para agentes antagonistas de bombas de protones

Country Status (3)

Country Link
CN (1) CN1767817A (es)
DE (1) DE10317023A1 (es)
EC (1) ECSP056039A (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10835541B2 (en) 2015-07-30 2020-11-17 Takeda Pharmaceutical Company Limited Tablet

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104027344B (zh) * 2014-06-20 2016-08-24 新乡医学院 包含林可霉素的药物组合物
CN111184867A (zh) * 2020-03-19 2020-05-22 龚跃明 治疗幽门螺杆菌感染的化学药物组合物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10835541B2 (en) 2015-07-30 2020-11-17 Takeda Pharmaceutical Company Limited Tablet

Also Published As

Publication number Publication date
DE10317023A1 (de) 2004-11-11
CN1767817A (zh) 2006-05-03

Similar Documents

Publication Publication Date Title
CY1120377T1 (el) Στερεη φαρμακευτικη δοσολογικη φαρμακοτεχνικη μορφη που περιεχει λοπιναβιρη
NO20063393L (no) Farmasoytiske preparater
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
DK1521573T3 (da) Ikke-polymere, lipofile, farmaceutiske implantatsammensætninger til intrakulær anvendelse
CL2008000418A1 (es) Uso de un antagonista de la il-23 para el tratamiento de una infeccion fungica.
BRPI0606339A2 (pt) formas farmacêuticas resistentes a álcool
UY29562A1 (es) Compuestos heterocíclicos de amino benzoilo, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones
NO20052739D0 (no) CCR5-antagonister som medikamenter
CO6362017A2 (es) Peptidos antivirales terapeuticos
BRPI0815894A2 (pt) Composição farmacêutica, uso da mesma, e, sais farmaceuticamente aceitáveis de um composto.
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
DK1814848T3 (da) 2,3,4-substitueret-cyclopentanoner som terapeutiske midler
RS20050868A (en) Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
NO20055207L (no) Oralt farmasoytisk preparat for protonpumpeantagonister
NO20080219L (no) Fentanylformulering som inneholder en essensiell olje
NO20063293L (no) Farmasoytiske forbindelser
ECSP056039A (es) Formulacion farmaceutica peroral para agentes antagonistas de bombas de protones
DK1865931T3 (da) Transdermal plaster
UY29561A1 (es) Derivados de quinazolina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones
EA200600953A1 (ru) Дозированные формы торсемида пролонгированного высвобождения
ATE529432T1 (de) Azazyklosteroid als ligande der histamin-3 rezeptoren
BRPI0417265A (pt) composição farmacêutica compreendendo um princìpio ativo e sulfobetaìna
ATE551999T1 (de) P-glycoprotein-hemmer mit octiloniumbromid als wirkstoff
EA200901387A1 (ru) Фармацевтическая композиция, включающая дезлоратадин
DK1420789T3 (da) Anvendelse af aktivstoffer med my-opioid-receptoragonistisk virkning og opioid-receptorantagonistisk virkning som kombinationslægemidler til cancerbehandling